In addition, whereas the selection of DNMT3A‐mutant and wildtype HSPCs from the same counterparts allowed the comparison between HSPCs part of a CH clone and their matched counterparts, our targeted approach did not allow inference of the clonal diversity of HSPCs in the phylogenies of the HCT recipients. The gene discussed is DNMT3A; the disease is cyclic hematopoiesis.